about
MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from the human amniotic membrane, birth tissues, and human skin & bone. Its products are targeted towards the wound-care, burn, surgical, sports medicine, an...
Read More
5.42
-0.33
(-5.74%)
1.5M
XNAS Volume
XNAS 16 Jan, 2026 4:30 PM (EST)
Medium Financial Strength
Mid Valuation
Technically Bearish
Slowing Down Stock
These stocks have medium financials and valuations, but weak momentum indicating decreasing investor interest
View Similar
Embed DVM
Mimedx Grp Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..